Boston Scientific/Aspect Medical
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific makes $10 mil. equity investment in Aspect and is providing an additional $5 mil. credit facility to support development of Aspect's Bispectral Index (BIS) anesthetic effect/brain monitoring technology for use in gastrointestinal endoscopy, interventional cardiology and radiology suites. The BIS is currently available in intensive care units and operating rooms (11"The Gray Sheet" Feb. 4, 2002, p. 18). In return, Aspect has granted Boston Scientific an option for worldwide distribution rights for the specialty procedures market, as well as an option to purchase up to an aggregate of 25% of Aspect's voting securities in the open market...
You may also be interested in...
Aspect Enters ICU With BIS Anesthesia Monitor Technology: $675 Mil. Market
Aspect Medical Systems intends to expand into the $300-$350 mil. market for emergency room and interventional radiology applications with the BIS XP Bispectral Index anesthesia monitoring technology platform within nine to 15 months, the firm says
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.